Author: admin

Halo Infinite: S&D Extraction (Seek and Deploy) | Halo
The time has come – S&D Extraction arrives TODAY in Halo Infinite and we’re going to breakdown what you can expect. Let’s jump right in.

For the uninitiated, S&D Extraction (Seek and Deploy) is an all-new mode based on the classic tactical FPS genre.
- Sandbox: All of your movement capabilities, shield health, weapon damage / traits are all the same and what you would expect out of Halo Infinite.
- Round based: The mode is a Best of 11 rounds, where the first to win 6 rounds will claim victory in the match.
- Extraction: In other tactical games players carry a bomb – well, in S&D Extraction there is no bomb, and instead you go to either A or B sites to plant the Extraction device. This means that anyone can plant on Offense and you don’t need to worry about who carries the bomb.
- One sided: Each team will take turns on Offense and Defense. On Offense, your job is to plant the Extraction device and either eliminate everyone on Defense or successfully extract the device. On Defense, you have to stop the enemy team from planting either by wiping them out, stopping them from planting within the 90 second round, or “defusing” the Extraction device after it’s been planted.
- Economy: Based on individual and team performance, each player will earn points that they can spend next round. The more kills, assists, and round wins you get – the more points you get.
- Custom Loadouts: While each player starts with Bandit Evo, you’ll have a chance at the beginning of each round to upgrade your loadout with the points you’ve earned including weapons, grenades, and equipment. Do you spend each round, or do you save your points for the big spend? Each round your items get reset, so only buy something if you know you’re going to use it.
- Buy Back: Players with enough points can buy back into a round after they’ve died to provide reinforcements to the team in times of need. It’s expensive though so decide wisely and once you buy back, you’ll just have your Bandit Evo and won’t be able to buy anything else.
The entire mode was scripted in Forge, and Halo Studios hired none other than Artifice to make this design and vision come to life. Thank you, Artifice, for your hard work and masterful skill scripting in Forge.

S&D Extraction will launch with two playlists:
- Ranked
- Social /Unranked
The Unranked playlist will be available for a limited time, and the Ranked playlist will become part of the monthly rotationals.

The S&D Extraction playlists will launch with (6) total maps made exclusively for this mode.

For the first map titled Hangar 18, Halo Studios hired Mikrips from the community to design and art this amazing map. Thank you Mikrips for your work on this map and for your close partnership in designing and fine tuning this map from beginning to end.

The remaining 5 maps were chosen from the finalists from the Forgehub S&D Extraction contest earlier this year. We want to thank the entire Forgehub staff for running this competition, and of course matching our prize pool contributions. And thank you to the over 50 Forgers that submitted their maps into the contest after working so hard to complete their maps in time for the tight deadline. Thank you!

HANGAR 18 by MikRips

ABRASION by ExtraDot

HOLLOWED by Zaddy Hammer

FRACTURE by SilencerEU, UnknownEmerald, KatRatATat, Squally DaBeanz

ELLIPSE by mysh0tisntsik

ASHORE by ADSR

When we set out to make this mode, we wanted to make something new, competitive, and fun that Halo’s never had before. So while this won’t be featured on the mainstage in HCS, we hope that players have a blast and we can’t wait to see all the epic moments that come out of it!
Continue Reading
July 8, 2025
SimonMed Imaging Launches Advanced AI Mammogram Services for Breast and Heart Health

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has launched Mammogram+ and Mammogram+ Heart, two new AI-enhanced mammogram services aimed at improving early detection and advancing preventative care.

Mammogram+ is SimonMed’s most advanced breast cancer screening to date. By combining two AI technologies with expert breast radiologist review, Mammogram+ is designed to spot cancer earlier and deliver more personalized insights on their breast density, lifetime risk. This service replaces the previous PBCD (Personalized Breast Cancer Detection) program.

“At SimonMed Imaging, we’re focused on empowering women with the latest technology to take charge of their health,” said Dr. John Simon, CEO and Founder of SimonMed Imaging. “Mammogram+ and Mammogram+ Heart combine advanced AI to detect breast cancer earlier and identify early signs of heart disease—offering valuable insight into both breast and heart health through a single exam.”

Building on this new technology in breast health, Mammogram+ Heart enhances standard mammography by incorporating an AI-based assessment of Breast Arterial Calcification (BAC), an emerging clinical marker linked to cardiovascular risk in women. This dual-purpose screening enables detection of both breast cancer and early signs of heart disease in a single appointment.

Mammogram+ and Mammogram+ Heart are now available at SimonMed locations nationwide that offer mammography services. These are optional add-ons that can be included with a standard screening mammogram. No referral is needed for patients to include either service as part of their regular mammogram.

“Women deserve the best tools available when it comes to detecting disease early,” said Dr. Angela Fried, Director of Breast Imaging at SimonMed. “With Mammogram+ and Mammogram+ Heart, we’re offering more than a scan—we’re delivering deeper insight, earlier intervention, and more empowered care.”

This launch reflects SimonMed’s ongoing mission in AI-driven diagnostics, accessible innovation, and lifesaving screening tools designed around real patient needs. As breast cancer and cardiovascular disease diagnoses continue to rise, these newly added services aim to close the gap in early detection.

Learn more at www.simonmed.com.

Continue Reading

July 8, 2025
Melting glaciers are awakening Earth’s most dangerous volcanoes

Melting glaciers may be silently setting the stage for more explosive and frequent volcanic eruptions in the future, according to research on six volcanoes in the Chilean Andes.

Presented today (July 8) at the Goldschmidt Conference in Prague, the study suggests that hundreds of dormant subglacial volcanoes worldwide – particularly in Antarctica – could become more active as climate change accelerates glacier retreat.

The link between retreating glaciers and increased volcanic activity has been known in Iceland since the 1970s, but this is one of the first studies to explore the phenomenon in continental volcanic systems. The findings could help scientists better understand and predict volcanic activity in glacier-covered regions.

Researchers from the University of Wisconsin-Madison, USA, used argon dating and crystal analysis across six volcanoes in southern Chile, including the now dormant Mocho-Choshuenco volcano, to investigate how the Patagonian Ice Sheet’s advance and retreat influenced past volcanic behaviour. The work is in collaboration with researchers from Lehigh University, University of California Los Angeles, and Dickinson College.

By precisely dating previous eruptions and analysing crystals in erupted rocks, the team tracked how the weight and pressure of glacial ice alter the characteristics of magma underground.

They found that during the peak of the last ice age (around 26,000-18,000 years ago), thick ice cover suppressed the volume of eruptions and allowed a large reservoir of silica-rich magma to accumulate 10-15 km below the surface.

As the ice sheet melted rapidly at the end of the last ice age, the sudden loss of weight caused the crust to relax and gasses in the magma to expand. This buildup of pressure triggered explosive volcanic eruptions from the deep reservoir, causing the volcano to form.

Pablo Moreno-Yaeger from the University of Wisconsin-Madison, USA, is presenting the research at the Goldschmidt Conference. He said: “Glaciers tend to suppress the volume of eruptions from the volcanoes beneath them. But as glaciers retreat due to climate change, our findings suggest these volcanoes go on to erupt more frequently and more explosively. The key requirement for increased explosivity is initially having a very thick glacial coverage over a magma chamber, and the trigger point is when these glaciers start to retreat, releasing pressure – which is currently happening in places like Antarctica.

“Our study suggests this phenomenon isn’t limited to Iceland, where increased volcanicity has been observed, but could also occur in Antarctica. Other continental regions, like parts of North America, New Zealand and Russia, also now warrant closer scientific attention.”

While the volcanic response to glacial melting is almost instant in geological terms, the process of changes in the magma system is gradual and occurs over centuries, giving some time for monitoring and early warning.

The researchers also note that increased volcanic activity could have global climate impacts. In the short term, eruptions release aerosol (tiny particles in gases) that can temporarily cool the planet. This was seen after the 1991 eruption of Mount Pinatubo in the Philippines, which reduced global temperatures by approximately 0.5 degrees C. But with multiple eruptions, the effects reverse.

“Over time the cumulative effect of multiple eruptions can contribute to long-term global warming because of a buildup of greenhouse gases,” said Moreno-Yaeger. “This creates a positive feedback loop, where melting glaciers trigger eruptions, and the eruptions in turn could contribute to further warming and melting.”

The research was funded by the National Science Foundation as part of a grant led by Professor Brad Singer at UW-Madison, and is due to be published in a peer-reviewed journal later this year.

The Goldschmidt Conference is the world’s foremost geochemistry conference. It is a joint congress of the European Association of Geochemistry and the Geochemical Society (US), and over 4000 delegates attend. It takes place in Prague, Czech Republic, from July 6-11 2025.

Continue Reading

July 8, 2025
Peter Jackson Wants to Bring Flightless Bird Moa Back From Extinction

Colossal Biosciences — which announced in April that it had brought dire wolves back from extinction (only to be met with a howl of critics who called the claims overstated) — is teaming up with filmmaker Peter Jackson on a new animal revival project.

The company announced Tuesday that it is working with Jackson and New Zealand’s Ngāi Tahu Research Centre to bring back the moa, native flightless birds that went extinct around 600 years ago. Found nowhere else on Earth, moas comprised nine species — with the largest, the South Island Giant Moa, clocking in at around 400 pounds with a height of up to 12 feet when its neck was outstretched. That made it likely the tallest ever bird ever to have existed.

“I would hope eventually we can bring back all nine species of moa to really see and understand them and study them,” Jackson tells The Hollywood Reporter, adding that the collaborators hope to bring back the South Island Giant Moa first. It, along with other moas, went extinct around 150 years after Polynesians settled in New Zealand.

“When you grow up in New Zealand, you grow up knowing about the moa. It’s just something that’s in our DNA,” continues Jackson, who, along with his partner Fran Walsh, invested $10 million in Colossal Biosciences last year.

Long fascinated by the moa, Jackson and Walsh have been collecting bones of the extinct bird for years. “We’ve collected about 400 moa bones,” says Jackson, explaining that they urged Colossal to add the moa to the list of species the company plans to resurrect from extinction. (The company has previously detailed plans to bring back the Tasmanian tiger, the woolly mammoth and the dodo.)

“When we had our first Zoom call with Colossal a couple of years ago, the moa wasn’t on their list on their website. We said to them, ‘Are you interested in the moa? And [Colossal co-founder] Ben [Lamm] said, ‘Yeah, we sure are. So we made a condition of our investment that all of our dollars go into the moa project.” As part of the agreement, Jackson and Walsh are giving Colossal the use of their collection of moa bones for research. “So we were able to not just invest in Colossal, but also bring our bones to the table, as it were,” continues Jackson, whose upcoming projects include producing Lord of the Rings: The Hunt for Gollum, set for release in 2027. “And they’ve been sampled for DNA. We were very pleased about that.”

In its request to bring back extinct animals, Colossal Biosciences uses a combination of genome mapping — using still-extant tissue and bones — and pioneering genetic engineering. The animals are not directly cloned from decades- or centuries-old tissue. Instead, a living, closely related species is genetically edited to produce the closest scientifically possible match of the extinct species. In the case of Colossal’s trumpeted dire wolves, the animals were created by developing the most complete genetic map ever made of the extinct species and then making 20 genetic edits of the genetic code of a near-cousin, the grey wolf, selecting for specific dire wolf characteristics. Some scientists have criticized Colossal’s dire wolf claims as “misleading,” saying that it’s an exaggeration to say that the species has altogether been brought back from extinction.

To resurrect the moa — which was the subject of a 1973 DC Action Comics book in which it fought Superman — Colossal will need to work with the genetic code of the closely related tinamou bird, which is native to the Americas. Colossal Biosciences has already begun building reference genomes of the tinamou as well as of the emu, Australia’s species of large flightless bird. “We started in October on this project,” says Lamm. “In the next year, the project is really about sequencing bones and getting more and more [moa] samples and the research so we know what are the edits that need to be made.”

The moa project is a partnership between the Ngāi Tahu Research Centre, Colossal and Jackson. The research center — which will take the lead in directing the moa efforts — was established in 2011 to support the Ngāi Tahu, the principal iwi (Māori tribe) of the southern region of New Zealand. In contrast to its work with other animals, explains Lamm, “we’ve taken a different approach [with the moa] where we are almost like a support function to the Māori.” Colossal believes the partnership “signals a new era of indigenous leadership in scientific innovation.”

Kyle Davis, a Ngāi Tahu archaeologist who is working with Colossal and Jackson, explains the importance of the extinct bird to Māori culture. “This animal features in our oral histories. It’s iconic and what we call a taonga, a treasured entity from the past. It’s hugely significant to us,” says Davis, adding that “Peter [Jackson] is, through the cinematic medium, a world builder. And Colossal is a world preserver and restorer. So for them to accept the invitation to share our tribal dream of ecological restoration and adding de-extinction to that milieu is just an absolute honor and privilege.”

If the partnership is successful, it’s likely that the birds will live in an ecological preserve in New Zealand. “The concept isn’t to release the giant moa into the wild. That’s certainly not the initial goal,” says Jackson. “New Zealand’s a very different country now to how it was 600 years ago. There’s roads, there’s cars, there’s cities, there’s so many more people. It’s not necessarily a good idea to just release it into the wild. That may happen, but it would happen, I think, decades down the track. It would have to happen after a lot of studying, a lot of thinking.”

Adds Lamm, “Going back to the spirit of the partnership, it’s really up to the Ngāi Tahu. It’s really up to what they want. We look at ourselves as supporters of their vision.”

Lamm, calling the moa project a “redemption story,” hopes that the efforts will inspire interest in ecology and biodiversity and drive ecotourism to New Zealand. As part of its commitment, Colossal Biosciences will also invest funds in helping preserve other species in New Zealand which are currently threatened with extinction or loss of abundance. “Saving and protecting what’s there — at the direction of the Ngāi Tahu Research Centre — is something that’s critical to the project,” says Lamm.

Continue Reading

July 8, 2025
Shaping the future of psychiatry with precision medicine

In a comprehensive Genomic Press Interview published today in Genomic Psychiatry, Dr. Mirko Manchia opens up about his transformative journey from a small Sardinian city to becoming a leading voice in psychiatric pharmacogenomics, revealing how personal family experiences with mental illness sparked a lifelong quest to understand why psychiatric medications work brilliantly for some patients while failing others.

The Associate Professor of Psychiatry at the University of Cagliari has spent decades unraveling one of psychiatry’s most perplexing puzzles: why does lithium, psychiatry’s oldest mood stabilizer, transform some bipolar patients’ lives while leaving others searching for alternatives?

From personal experience to scientific breakthrough

Growing up in Sassari with no medical background in his family, Dr. Manchia’s path into neuroscience began with what he describes as “profound familial events” during adolescence that connected him deeply with mental health. This personal connection would later fuel groundbreaking research that culminated in a landmark publication in The Lancet, identifying genome-wide significant associations for lithium response in bipolar patients.

“I saw patients who had severe illness trajectories and who had remained well after several years of treatment with mood stabilizers, especially lithium, while others experienced continuous recurrences with dire consequences on their lives,” Dr. Manchia reflects in the interview. This observation became the cornerstone of his research philosophy.

Building international collaborations

As a co-investigator and founding member of the International Consortium on Lithium Genetics (ConLiGen), Dr. Manchia has helped coordinate one of psychiatry’s most ambitious pharmacogenetic efforts. His meticulous phenotypic analysis of patient samples has been instrumental in identifying genetic markers that could predict treatment response before patients endure months of trial-and-error medication adjustments.

The impact extends far beyond lithium. With 230 peer-reviewed publications spanning molecular genetics and clinical psychiatry, Dr. Manchia has established himself as a bridge between laboratory discoveries and real-world patient care. His dual appointments at Cagliari and Dalhousie University in Canada reflect this international reach.

Precision medicine takes center stage

Currently serving as chair of the European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network, Dr. Manchia envisions a future where genetic testing becomes routine in psychiatric care. “We are at a point in psychiatric genetics where clinical utility is emerging,” he states. His current focus includes developing healthcare pathways that integrate pharmacogenetic testing for treatment-resistant depression and implementing AI-based predictive tools.

What makes this vision particularly compelling is its practical application. Rather than pursuing abstract genetic associations, Dr. Manchia’s work centers on questions every psychiatrist faces: Which patient will respond to this medication? How can we minimize the devastating trial-and-error period that often characterizes psychiatric treatment? Can we predict and prevent treatment resistance before it develops?

Addressing research disparities

The interview also highlights a critical challenge facing psychiatric research: chronic underfunding compared to other medical specialties. Dr. Manchia advocates for increased investment, noting that oncology’s transformation followed massive research funding. “This could also be achieved in psychiatry, but we need to act in a harmonized way, involving all stakeholders, particularly patient and family associations,” he emphasizes.

His approach to this challenge reflects the same patient-centered philosophy that drives his research. By involving patient organizations in research development and dissemination, Dr. Manchia believes the field can build the public support necessary for sustained funding increases.

Looking ahead: Digital integration and beyond

The interview reveals Dr. Manchia’s vision for psychiatry’s future, where digital monitoring, psychometric assessments, genomics, and brain imaging converge into comprehensive predictive models. Within 20 years, he predicts, these integrated approaches will fundamentally transform how mental health is managed and delivered.

Yet despite these technological advances, Dr. Manchia’s motivations remain deeply human. When asked about his greatest passion beyond science, he mentions Roman history, classical music, and playing guitar – reminders that even cutting-edge researchers need balance and perspective.

Dr. Mirko Manchia’s Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today’s most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that explore the scientist’s impact on the field, while also touching on broader human themes. More information on the research leaders and rising stars featured in our Innovators & Ideas – Genomic Press Interview series can be found in our publications website: https://genomicpress.kglmeridian.com/.

Source:

Journal reference:

Manchia, M., (2025) Mirko Manchia: Exploring the biological landscape of psychiatric disorders to innovate clinical management with precision medicine approaches. Genomic Psychiatry. doi.org/10.61373/gp025k.0071.

Continue Reading

July 8, 2025
Google Maps is now available on Garmin’s smartwatches

Garmin has announced that a free Google Maps app is now available for most of the company’s smartwatches that lets you know where and how far your next turn is while walking, cycling, or running.

Unlike the more robust version of Google Maps available for Wear OS that can be used to search for destinations and even navigate without a smartphone, Garmin’s Google Maps app has limited functionality, similar to Google Maps on the Apple Watch. The Garmin app only provides basic turn-by-turn directions and you need to locate your destination using the Google Maps mobile app on an Android smartphone that has to be kept in range. On the app’s listing on Garmin’s Connect IQ store, there’s no mention of support for iPhones or iOS.

Garmin says the app will gently vibrate your smartwatch when the next turn is delivered so you don’t need to be constantly looking at your wrist, and the app can show you your next three turns by simply tapping the screen. Your smartwatch will also continue to record your walking, running, and biking performance while you’re using the Google Maps app for navigation.

The Google Maps app is now available for download from Garmin’s Connect IQ Store and is compatible with upwards of 90 different models of its smartwatches.

Continue Reading

July 8, 2025
England Urged to Unleash Archer in Crucial Lord’s Test Against India

England are being strongly encouraged to bring Jofra Archer back into the Test arena for the pivotal third match against India at Lord’s on Thursday, as the five-match ICC World Test Championship series hangs in the balance at 1-1.

Veteran pacer James Anderson has publicly called for Archer’s inclusion, insisting that the time to gamble on the fast bowler’s fitness is now, not later in the series. Archer, who last played a Test over four years ago, recently returned to red-ball action with Sussex and was part of the England squad during the second Test at Edgbaston, which England lost by a heavy 336-run margin.

“You could keep trying to build his overs up and play him later in the series, but it could be too late by then,” Anderson said on the Tailenders Podcast. “I just feel like you’ve got to play him. It’s too crucial a game not to.”

England head coach Brendon McCullum confirmed Archer is fit and available, saying the 29-year-old is “looking strong” and is “buzzing” to be back with the team.

“We all know what he’s capable of achieving in Test cricket,” McCullum noted. “We hope that when the opportunity does arrive for him, he’s able to recapture and also improve on what he’s been able to do already.”

Alongside Archer, England are weighing up the inclusion of fast bowler Gus Atkinson and back-up batter Jacob Bethell. Atkinson has been sidelined since injuring his hamstring in May, while Bethell—who has only three Test caps—would serve as a batting option rather than a replacement for first-choice spinner Shoaib Bashir.

“He [Bethell] wants to keep improving his bowling… but it’s not something we’d look at from a tactical point of view to do,” McCullum added.

As the series intensifies and momentum swings toward India, all eyes are on England’s selection strategy—and whether Archer will be the x-factor return at the Home of Cricket.

England squad for third Test at Lord’s: Ben Stokes (c), Jofra Archer, Gus Atkinson, Shoaib Bashir, Jacob Bethell, Harry Brook, Brydon Carse, Sam Cook, Zak Crawley, Ben Duckett, Jamie Overton, Ollie Pope, Joe Root, Jamie Smith, Josh Tongue, Chris Woakes.

Continue Reading

July 8, 2025
Finnish researchers break quantum record with millisecond-long qubit coherence-Xinhua

HELSINKI, July 8 (Xinhua) — Researchers at Finland’s Aalto University have achieved a breakthrough in quantum computing by extending the coherence time of a transmon qubit to the millisecond level, setting a new global scientific record, the university announced on Tuesday.

The milestone, published in the journal Nature Communications, marks a significant improvement over previous records, which had reached approximately 0.6 milliseconds. According to Aalto University, the researchers measured a maximum echo coherence time of one millisecond, with a median time of 0.5 milliseconds, both of which surpassed earlier benchmarks.

Qubit coherence is a key parameter in quantum computing, determining how long a qubit can maintain its quantum state. Longer coherence times enable quantum computers to perform more complex and error-free computations, the researchers explained.

Longer coherence times also allow more calculations on noisy quantum systems while reducing the resources needed for quantum error correction – a step toward fault-tolerant, noiseless quantum computing, the university noted.

Experts say the findings represent an important step toward scalable, reliable quantum computers, laying another foundation for future advancements in the global pursuit of quantum technologies.

The achievement was made by the Quantum Computing and Devices (QCD) research group at Aalto University’s Department of Applied Physics. The work is part of the Academy of Finland Centre of Excellence in Quantum Technology and the Finnish Quantum Flagship initiative.

The qubit was fabricated by the QCD group at Aalto using high-quality superconducting film supplied by the Technical Research Centre of Finland.

“This landmark achievement has strengthened Finland’s standing as a global leader in the field, moving the needle forward on what can be made possible with the quantum computers of the future,” said Mikko Mottonen, professor of quantum technology and head of the QCD group.

Following the successful demonstration, the research team has also opened new research positions to accelerate progress in the field. ■

Continue Reading

July 8, 2025
Tour de France 2025 results: Tadej Pogacar claims 100th victory on stage four

Defending champion Tadej Pogacar outsprinted Mathieu van der Poel and Jonas Vingegaard as he claimed his 100th professional victory on stage four of the Tour de France.

The result means that the Slovenian moves level on time with Dutch rider at the top of the general classification with Van der Poel retaining the leader’s yellow jersey on count-back.

With five categorised climbs in the final 50km of the 174.2km route into Rouen, all the main favourites were involved in a series of attacks that split the race open and delivered a compelling finale.

However, Pogacar, delivered a show of strength on another classics-style stage to surge away from Van der Poel in an uphill dash to the finish having initially distanced all his rivals, bar Danish rival Vingegaard, on the short but punishing climb up the Rampe Saint-Hilaire, five kilometres out.

“I hope today that everyone was on the limit. I tried with an attack on the second last climb and last climb and Jonas [Vingegaard] followed me and everything came together,” Pogacar said.

“Joao [Almeida] did such an amazing job to lead me out to the end even if everyone was attacking. I am super proud of the team today. Amazing. It was such a nice victory.

“To win at the Tour is incredible, in this jersey even more and to have 100 victories is amazing.

“With so many good riders in the final, you’re always a bit on the edge and nervous about what’s going to happen. You get this adrenaline and it’s pure racing and I enjoy it.”

It is the 18th time Pogacar, 26, has won a stage in cycling’s greatest race as he goes for a fourth Tour triumph.

Meanwhile, Scotland’s Oscar Onley, 22, who is featuring in only his second Tour, produced a superb ride despite being delayed by a late crash to finish fourth among the elite GC riders, to move up to seventh in the overall race.

On Wednesday the riders tackle the first of two individual time trials on a 33km course around Caen, on a stage that Remco Evenepoel has been tipped to triumph in.

The 25-year-old Belgian world and Olympic champion in the discipline is currently almost a minute down on Pogacar in the GC race.

Continue Reading

July 8, 2025
PM, MNAs discuss matters pertaining to respective constituencies – RADIO PAKISTAN
1. PM, MNAs discuss matters pertaining to respective constituencies RADIO PAKISTAN
2. DPM Dar reaffirms government’s commitment to translating investment into tangible economic gains Ptv.com.pk
3. PM Shehbaz meets lawmakers, receives praise for economic stabilization efforts dailyindependent.com.pk
4. Foreign investments in key sectors discussed Business Recorder
5. Former MNA Abid Raza Kotla calls on Prime Minister Muhammad Shehbaz Sharif Associated Press of Pakistan
Continue Reading
July 8, 2025